Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
LINC00662 is a long non-coding RNA located on chromosome 19q11. It is involved in the regulation of gene expression through interactions with microRNAs and proteins, impacting various cellular processes like proliferation, migration, and invasion. Its overexpression is associated with poor prognosis in several types of cancer, suggesting it as a potential therapeutic target.
Functions as a ceRNA (competeting endogenous RNA) to regulate miRNA and mRNA expression. Interacts with proteins to influence gene expression and cellular processes.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Long intergenic non-protein coding RNA 662 (LINC00662).